This grant opportunity (PAR-25-075) from the NIH focuses on assay validation of high-quality markers for clinical studies in cancer. UH3 clinical trials are not allowed under this funding opportunity (CFDA 93.394).
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.